Solasia Pharma KK
TSE:4597
Net Margin
Solasia Pharma KK
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | JP |
| Market Cap | 5.4B JPY |
| Net Margin |
-180%
|
| Country | US |
| Market Cap | 285.4B USD |
| Net Margin |
9%
|
| Country | US |
| Market Cap | 167B USD |
| Net Margin |
13%
|
| Country | US |
| Market Cap | 110.4B USD |
| Net Margin |
37%
|
| Country | US |
| Market Cap | 108.5B USD |
| Net Margin |
29%
|
| Country | AU |
| Market Cap | 135.1B AUD |
| Net Margin |
17%
|
| Country | US |
| Market Cap | 84.3B USD |
| Net Margin |
2%
|
| Country | US |
| Market Cap | 49.1B USD |
| Net Margin |
-116%
|
| Country | US |
| Market Cap | 43.1B USD |
| Net Margin |
-33%
|
| Country | US |
| Market Cap | 33B USD |
| Net Margin |
12%
|
| Country | KR |
| Market Cap | 39.6T KRW |
| Net Margin |
25%
|
Profitability Report
View the profitability report to see the full profitability analysis for Solasia Pharma KK.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Solasia Pharma KK's most recent financial statements, the company has Net Margin of -180.2%.
You don't have any saved screeners yet
